380 related articles for article (PubMed ID: 11719829)
1. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
Carpentier A; Giacca A; Lewis GF
Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
[TBL] [Abstract][Full Text] [Related]
2. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men.
Leung N; Sakaue T; Carpentier A; Uffelman K; Giacca A; Lewis GF
Diabetologia; 2004 Feb; 47(2):204-13. PubMed ID: 14712348
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans.
Stefan N; Fritsche A; Madaus A; Häring H; Stumvoll M
Diabetologia; 2000 Nov; 43(11):1368-73. PubMed ID: 11126404
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.
Frias JP; Basabe L; Macaraeg G; Kruszynska YT
Diabetes Metab; 2000 Apr; 26(2):133-9. PubMed ID: 10804328
[TBL] [Abstract][Full Text] [Related]
5. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
Beysen C; Karpe F; Fielding BA; Clark A; Levy JC; Frayn KN
Diabetologia; 2002 Nov; 45(11):1533-41. PubMed ID: 12436337
[TBL] [Abstract][Full Text] [Related]
6. NEFA elevation during a hyperglycaemic clamp enhances insulin secretion.
Chalkley SM; Kraegen EW; Furler SM; Campbell LV; Chisholm DJ
Diabet Med; 1998 Apr; 15(4):327-33. PubMed ID: 9585399
[TBL] [Abstract][Full Text] [Related]
7. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects.
Paolisso G; Gambardella A; Amato L; Tortoriello R; D'Amore A; Varricchio M; D'Onofrio F
Diabetologia; 1995 Nov; 38(11):1295-9. PubMed ID: 8582538
[TBL] [Abstract][Full Text] [Related]
9. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
10. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
Dobbins RL; Chester MW; Daniels MB; McGarry JD; Stein DT
Diabetes; 1998 Oct; 47(10):1613-8. PubMed ID: 9753300
[TBL] [Abstract][Full Text] [Related]
11. Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.
Stefan N; Fritsche A; Häring H; Stumvoll M
Diabetes; 2001 May; 50(5):1143-8. PubMed ID: 11334419
[TBL] [Abstract][Full Text] [Related]
12. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
Mason TM; Goh T; Tchipashvili V; Sandhu H; Gupta N; Lewis GF; Giacca A
Diabetes; 1999 Mar; 48(3):524-30. PubMed ID: 10078552
[TBL] [Abstract][Full Text] [Related]
13. The effect of circulating non-esterified fatty acids on the entero-insular axis.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Eur J Clin Invest; 1999 Jan; 29(1):27-32. PubMed ID: 10092985
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man.
Amery CM; Round RA; Smith JM; Nattrass M
Metabolism; 2000 Apr; 49(4):450-4. PubMed ID: 10778867
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients.
Butler TJ; Barriocanal LA; Walker M
Clin Endocrinol (Oxf); 2001 Sep; 55(3):349-55. PubMed ID: 11589678
[TBL] [Abstract][Full Text] [Related]
16. Effects of heparin-induced non-esterified free fatty acid on minimal model-derived insulin sensitivity in individuals with varying degrees of glucose intolerance.
Osei K; Schuster DP
Diabet Med; 1995 Oct; 12(10):911-5. PubMed ID: 8846683
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
18. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden G; Chen X
Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
[TBL] [Abstract][Full Text] [Related]
19. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.
Marchesini G; Bianchi G; Rossi B; Muggeo M; Bonora E
Int J Obes Relat Metab Disord; 2000 May; 24(5):552-8. PubMed ID: 10849575
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 48-h fat infusion on insulin secretion and glucose utilization.
Boden G; Chen X; Rosner J; Barton M
Diabetes; 1995 Oct; 44(10):1239-42. PubMed ID: 7556964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
